PRM42 - COST MODEL OF SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILARS, FOR NON MEDICAL REASONS, IN RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2165
https://www.valueinhealthjournal.com/article/S1098-3015(18)35467-6/fulltext
Title :
PRM42 - COST MODEL OF SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILARS, FOR NON MEDICAL REASONS, IN RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35467-6&doi=10.1016/j.jval.2018.09.2165
First page :
Section Title :
Open access? :
No
Section Order :
1512